← Back to Search

Device

Bright Light Therapy for Frailty in Older Veterans (Brite-VET Trial)

N/A
Recruiting
Led By Bruce R. Troen, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to endpoint at 12 weeks
Awards & highlights

Brite-VET Trial Summary

This trial will study whether bright light therapy can reduce frailty, improve sleep & cognitive function in older Veterans.

Who is the study for?
This trial is for older veterans who may be frail and have early-stage health issues. It's open to both men and women living in the community, but not those who are very overweight, without sleep problems, or with severe illnesses or cognitive impairments.Check my eligibility
What is being tested?
The study tests Bright Light Therapy using AYO Glasses to see if they can help reduce frailty and improve cognition and sleep quality in elderly veterans by resynchronizing their biological clocks.See study design
What are the potential side effects?
Bright Light Therapy is generally safe but could potentially cause eye strain or headache. Since it involves light exposure, there might also be a risk of disrupted sleep patterns if used improperly.

Brite-VET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Amyloid beta 42/40 ratio
Anxiety and depression
Brain Derived Neurotrophic Factor (BDNF)
+16 more
Secondary outcome measures
Body Composition (Lean and fat mass)
Frailty assessment
Gait speed
+2 more

Brite-VET Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: BLT interventionActive Control1 Intervention
Bright light glasses that emit a more intense therapeutic blue light.
Group II: BLT controlPlacebo Group1 Intervention
Bright light glasses that emit a non-therapeutic blue light.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,606 Previous Clinical Trials
3,305,970 Total Patients Enrolled
Bruce R. Troen, MDPrincipal InvestigatorKansas City VA Medical Center, Kansas City, MO
2 Previous Clinical Trials
243 Total Patients Enrolled

Media Library

AYO Glasses (Device) Clinical Trial Eligibility Overview. Trial Name: NCT05631236 — N/A
Elderly Veteran Research Study Groups: BLT control, BLT intervention
Elderly Veteran Clinical Trial 2023: AYO Glasses Highlights & Side Effects. Trial Name: NCT05631236 — N/A
AYO Glasses (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05631236 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must potential participants meet to qualify for this experiment?

"Those who wish to join this medical trial must be veterans aged 65 and up, but no older than 85. The study is currently accepting a maximum of 35 participants."

Answered by AI

Does this particular clinical study cater to participants aged 55 or older?

"This clinical trial is available to patients aged 65-85. For those under 18, there are 6 trials and for seniors 143 studies have been made accessible."

Answered by AI

Could you describe the fundamental goals of this clinical investigation?

"This study's primary objective is to measure sleep chronotype at 12 weeks post-baseline. Secondary objectives include evaluating body composition with bioelectric impedance, gait speed over a 15 foot distance, and frailty assessment through the Fried Frailty Phenotype methodology."

Answered by AI

Are there any vacancies for potential participants in this clinical test?

"According to clinicaltrials.gov, the recruitment phase for this research has been concluded; it first began on February 1st 2023 and was last adjusted November 29th 2022. Although no longer enrolling patients, there are still 145 other studies actively recruiting across the world."

Answered by AI
~23 spots leftby Dec 2024